The FDA released a statement that they are changing the approved uses of emtricitabine/tenofovir (brand name Truvada) to include use in prevention of HIV transmission between partners where one partner is HIV-negative and the other partner is HIV-positive. This is only to be used in high risk scenarios and under the care of a physician with constant monitoring. For more detail, see the press release below.
Press Release
